These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 10733938)

  • 1. A novel protein MAJN binds to Jak3 and inhibits apoptosis induced by IL-2 deprival.
    Ji H; Zhai Q; Zhu J; Yan M; Sun L; Liu X; Zheng Z
    Biochem Biophys Res Commun; 2000 Apr; 270(1):267-71. PubMed ID: 10733938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical sites for the interaction between IL-2Rgamma and JAK3 and the following signaling.
    Tang W; Huo H; Zhu J; Ji H; Zou W; Xu L; Sun L; Zheng Z; Theze J; Liu X
    Biochem Biophys Res Commun; 2001 May; 283(3):598-605. PubMed ID: 11341766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
    Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
    EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between Jak3 and Nucleosome Assembly Protein 1.
    Ji HB; Zhai QW; Zhu JF; Sun LY; Liu XY; Zheng ZC
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2000; 32(1):4-8. PubMed ID: 12110904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain.
    Adachi M; Ishino M; Torigoe T; Minami Y; Matozaki T; Miyazaki T; Taniguchi T; Hinoda Y; Imai K
    Oncogene; 1997 Apr; 14(13):1629-33. PubMed ID: 9129156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
    Sudbeck EA; Liu XP; Narla RK; Mahajan S; Ghosh S; Mao C; Uckun FM
    Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pkn is a novel partner of cyclin T2a in muscle differentiation.
    Cottone G; Baldi A; Palescandolo E; Manente L; Penta R; Paggi MG; De Luca A
    J Cell Physiol; 2006 Apr; 207(1):232-7. PubMed ID: 16331689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis.
    Thomis DC; Lee W; Berg LJ
    J Immunol; 1997 Nov; 159(10):4708-19. PubMed ID: 9366394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line.
    Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Nakamura M; Van Snick J; Sugamura K
    Eur J Immunol; 1996 Jun; 26(6):1322-7. PubMed ID: 8647212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Jak family tyrosine kinase Jak3 is required for IL-2 synthesis by naive/resting CD4+ T cells.
    Thomis DC; Aramburu J; Berg LJ
    J Immunol; 1999 Nov; 163(10):5411-7. PubMed ID: 10553066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of IL-2 signaling.
    Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Sugamura K
    Leukemia; 1997 Apr; 11 Suppl 3():416-7. PubMed ID: 9209410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting to C-terminal myosin heavy chain may explain mechanotransduction involving focal adhesion kinase in cardiac myocytes.
    Fonseca PM; Inoue RY; Kobarg CB; Crosara-Alberto DP; Kobarg J; Franchini KG
    Circ Res; 2005 Jan; 96(1):73-81. PubMed ID: 15576648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of JAK3 expression and activation in human B cells and B cell malignancies.
    Tortolani PJ; Lal BK; Riva A; Johnston JA; Chen YQ; Reaman GH; Beckwith M; Longo D; Ortaldo JR; Bhatia K; McGrath I; Kehrl J; Tuscano J; McVicar DW; O'Shea JJ
    J Immunol; 1995 Dec; 155(11):5220-6. PubMed ID: 7594533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32.
    Sunayama J; Ando Y; Itoh N; Tomiyama A; Sakurada K; Sugiyama A; Kang D; Tashiro F; Gotoh Y; Kuchino Y; Kitanaka C
    Cell Death Differ; 2004 Jul; 11(7):771-81. PubMed ID: 15031724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-gamma activation site-like sequence upstream of the I epsilon exon in a human B cell line. Evidence for the involvement of Janus kinase 3 and interleukin-4 Stat.
    Fenghao X; Saxon A; Nguyen A; Ke Z; Diaz-Sanchez D; Nel A
    J Clin Invest; 1995 Aug; 96(2):907-14. PubMed ID: 7635985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor-induced upregulation of Jak3 transcription during granulocytic differentiation is mediated by the cooperative action of Sp1 and Stat3.
    Mangan JK; Tantravahi RV; Rane SG; Reddy EP
    Oncogene; 2006 Apr; 25(17):2489-99. PubMed ID: 16518416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perturbing interactions.
    Milstein S; Vidal M
    Nat Methods; 2005 Jun; 2(6):412-4. PubMed ID: 15908918
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypervariable genes--experimental error or hidden dynamics.
    Dozmorov I; Knowlton N; Tang Y; Shields A; Pathipvanich P; Jarvis JN; Centola M
    Nucleic Acids Res; 2004 Oct; 32(19):e147. PubMed ID: 15514108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.